Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1☆0602 status
Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1☆0602 status
复制标题
DOI:
10.1183/09031936.00174609
复制
发表时间:
2010-09-01
影响因子:
24.3
通讯作者:
Strohl, K. P.
中科院分区:
文献类型:
--
作者:
Han, F.;Mignot, E.;Strohl, K. P.
We hypothesised that hypocretin (orexin) plays a role in the determination of ventilatory chemosensitivity. 130 patients with narcolepsy-cataplexy (mean +/- SD age 20 +/- 10 yrs, 69% male) and 117 controls (22 +/- 6.9 yrs, 62% male) were recruited and tested for human leukocyte antigen (HLA)-DQB1(star)0602 status, hyperoxia hypercapnic (change in minute ventilation (Delta V'E)/carbon dioxide tension (Delta PCO2) L.min(-1.)mmHg(-1)) and hypoxic (Delta V'E /change in arterial oxygen saturation measured by probe oximetry (Delta Sp,O-2) L.min(-1) per % Sp,O-2) responsiveness, and by spirometry. Hypocretin deficiency was determined either by measures of cerebrospinal fluid hypocretin-1 (37 patients) or by positive HLA-DQB1(star)0602 status. All patients and 49% of controls underwent polysomnography and multiple sleep latency testing. Despite similar spirometric values, patients had a higher apnoea/hypopnoea index (AHI) (2.8 +/- 5.4 versus 0.8 +/- 1.6 h(-1); p=0.03) and lower minimal oxygen saturation during sleep (87%+/- 7 versus 91 +/- 4%; p=0.0002), independent of age, sex and body mass index. Patients had depressed hypoxic responsiveness (0.13 +/- 0.09 versus 0.19 +/- 0.13 L.min(-1) per % Sp,O-2; p